跳至主要内容
临床试验/DRKS00000345
DRKS00000345已完成未知

Dietary supplementation with omega-3-fatty acids in patients with pancreatic cancer and weight loss: marine phospholipids versus fish oil - Phosfood II

Internationales Pankreaskarzinomzentruman der Abteilung für Allgemein- und ViszeralchirurgieUniversitätsklinikum Freiburg0 个研究点目标入组 60 人开始时间: 2010年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients suffering from pancreatic cancer who are under medical care of the International Pancreatic Cancer Center Freiburg:
  • o Post-surgical: Patients who underwent surgery at least 4 weeks ago and are back on normal nutrition
  • o Palliative: Patients who are either receiving chemotherapy or best supportive care
  • - age greater than/equal to 18 years
  • - Patients with a life expectancy of at least 3 months
  • - Written informed consent
  • - Patients with a weight loss greater than/equal to 5 % of body weight since first diagnosis
  • - Karnofsky index greater than/equal to 60 %

排除标准

  • - Patients with a known allergy to fish or seafood
  • - Patients who cannot eat normally
  • - Patients with a weight loss greater than 15 % of total body weight since first diagnosis
  • - Patients with known disturbance of resorption which cannot be alleviated by enzyme substitution
  • - Patients suffering from disturbed coagulation
  • - Patients already taking Omega-3 formulations or other dietary supplements as well as pharmaceuticals which may influence the trial outcome
  • - Patients suffering from severe concomitant diseases
  • - Patients with psychiatric or neurological disorders which may impair ability to consent
  • - Patients already participating in other clinical trials

研究者

发起方
Internationales Pankreaskarzinomzentruman der Abteilung für Allgemein- und ViszeralchirurgieUniversitätsklinikum Freiburg

相似试验